Israel Institute for Biological Research (IIBR) Archives

The BriLife vaccine will be tested in Georgia as part of Phase II trials, August 15, 2021. Photo: Ministry of Defense Spokesperson’s Office

Israeli COVID-19 Vaccine Developer Begins Phase II Trial In Georgia

The BriLife jabs arrived in Georgia over the weekend to begin the trial, which will run simultaneously with trials in Israel.

News Briefs

August 15, 2021

The Israel Institute for Biological Research's COVID-19 vaccine. October 2020. Photo: Ministry of Defense Spokesperson's Office

Israeli COVID-19 Vaccine Developer Inks Deal To Complete Trials, Commercialize Jab

The BriLife vaccine will be tested in Phase II and III trials in Georgia, Ukraine, and Israel as part of a deal with NRx Pharmaceuticals.

Science

July 13, 2021

Israeli COVID-19 Vaccine Cleared For 2nd Phase Of Clinical Trial With 1,000 Volunteers

The 1st phase for the Israeli vaccine, with 80 volunteers, was completed successfully with no significant side effects.

News Briefs

December 15, 2020

Colorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (purple), isolated from a patient sample. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID

Israeli Bio-Defense Lab Says It Found An Antibody That ‘Neutralizes’ The Coronavirus

The Israel Institute for Biological Research (IIBR) announced that it completed a 'groundbreaking scientific development' toward a potential COVID-19 treatment.

Science

May 05, 2020